Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis Source: Eur Respir Rev, 30 (162) 210057; 10.1183/16000617.0057-2021 Year: 2021
A comparative study of conventional cytology and cell block method in the diagnosis of malignant pleural effusion. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006
Diagnostic efficacy and suitability of trans-thoracic ultrasound for pleural effusion detection–The future non-invasive gold-standard. (study of 4597 cases) Source: Virtual Congress 2021 – Thoracic ultrasound as a bedside clinical tool Year: 2021
Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021
The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
Novel therapeutic strategies against malignant pleural mesothelioma by selumetinib-loaded targeted nanoparticles. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
The smellprint of mesothelioma cells: intrinsic biomarkers for diagnosis and subtyping Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020
Breath analysis allows to predict treatment response in malignant pleural mesothelioma patients. Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021
Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=173 Year: 2005
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013
Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Malignant pleural mesothelioma: new treatments, new hopes? Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017 Year: 2017
Assessment of accuracy of clinical techniques for detection of pleural effusions: comparison with radiological methods Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002
Transbroncial cryobiopsy as a new diagnostic method - a feasibility study Source: Eur Respir J 2004; 24: Suppl. 48, 491s Year: 2004
Laboratorial characteristics of pleural effusions, a new diagnostic tool for pleuropulmonary paragonimus Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018